Federal Register Notice: FDA is issuing an Emergency Use Authorization (EUA) for an in vitro diagnostic device for detecting the novel influenza A (H7N9) virus (detected in China in 2013). FDA is issuing this authorization under the FD&C Act, as requested by Quidel Corporation. The authorization follows the 4/19/13 determination by the HHS secretary that there is a significant potential for a public health emergency that has a significant potential to affect national security or the health and security of U.S. citizens living abroad and that involves the novel influenza A (H7N9) virus. To view this notice, click here.